Raynovent

China
Guangzhou, Guangdong, China, 518000

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
4
Total equity funding
$132.3M
Last funding
Series C / $53.6M / 2022-12-30
Last equity funding
Series C / $53.6M
Investors
15
Lead investors
3
Articles
2

Founders and investors

Lead investors

BioTrack CapitalEFung CapitalEide Fund

Investors

Bank of CommunicationsBioTrack CapitalEFung CapitalHuatai Zijin InvestmentYijing Capital